Payer PolicyActive
Hemodialysis for Schizophrenia
AETNA-CPB-0291
Aetna
Effective: May 5, 2023
Updated: December 6, 2025
created · Dec 2, 2025
Policy Summary
Hemodialysis for schizophrenia is excluded — Aetna considers it experimental/investigational with no covered indications (CPT 90935, 90937 and ICD‑10 F20.0–F20.9, Z49.01–Z49.32, Z99.2 not covered for this indication). The key requirement is that effectiveness has not been demonstrated and Medicare’s National Coverage Determination likewise finds the evidence inconclusive and does not cover it.
Coverage Criteria Preview
Key requirements from the full policy
"No covered indications identified. Hemodialysis for the treatment of schizophrenia is considered experimental and investigational because the effectiveness of this approach has not been demonstrate..."
Sign up to see full coverage criteria, indications, and limitations.